BBIO BridgeBio Pharma, Inc.
NEUTRAL
Impact: 3/10
Insider Cluster (1 insider)
Insider cluster: 2 insiders, $1.3M total
Final — all horizons settled through T+60d
BBIO ▼ -11.89% at T+60d
NEUTRAL call ✗ call lost -11.89% · α vs SPY -23.30% · entry $74.32 → $65.48
Last close $67.37 (close Jun 8) · -9.35% from $74.32 entry
T+1d
-3.94%
call -3.94% · α -3.84%
$71.39
settled 3mo ago
T+5d
-4.55%
call -4.55% · α -3.64%
$70.94
settled 3mo ago
T+20d
-0.24%
call -0.24% · α -0.09%
$74.14
settled 2mo ago
T+60d
-11.89%
call -11.89% · α -23.30%
$65.48
settled 7d ago
Price Chart
Loading chart...
Executive Summary
BridgeBio Pharma CEO Kumar Neil was granted a total of 144,883 shares in non-cash awards and sold 9,690 shares in an open-market transaction worth approximately $662,441. The sale represents a small fraction of the company's market cap and is likely part of a pre-arranged trading plan.
Key Financial Metrics
Direction
selling
Total Value
$662.4K
Insiders
1
Actionable Insight
The sale is minor relative to company size and likely routine; monitor for additional sales or participation from other insiders to assess potential concern.
Key Facts
- CEO Kumar Neil received two non-cash stock awards totaling 144,883 shares with no economic value at grant.
- CEO sold 9,690 shares in an open-market transaction at $68.3634 per share, totaling $662,441.
- Total value of open-market sale is $662,441, representing approximately 0.0049% of BBIO's $13.6B market cap.
Financial Impact
$662,441 in open-market sales; no financial impact from non-cash grants
insider ownershipshare count (dilution from grants)
Risk Factors
- Non-cash grants may lead to future dilution, though standard for executive compensation.
- Single insider sale, even if small, could signal reduced conviction if followed by further selling.
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-BBIO-1773952120485 |
15 reports for BBIO
86%
Hit rate
best @ T+60▲ +11.89%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
13d ago
|
Press Release
| $66.44 $63.88 | ▼ −3.85% | ▼ −5.06% | $67.37 (+1.40%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $66.44 $65.48 | ▲ +1.44% | ▲ +1.91% | $67.37 (−1.40%) |
|
May 21, 2026
19d ago
|
144
| $69.12 $65.36 | ▼ −5.44% | ▼ −7.10% | $67.37 (−2.53%) |
|
May 19, 2026
21d ago
|
Insider Cluster
| $68.22 $68.45 | ▲ +0.34% | ▼ −1.47% | $67.37 (−1.25%) |
|
May 12, 2026
28d ago
|
Press Release
| $65.95 $65.32 | ▼ −0.96% | ▼ −1.03% | $67.37 (+2.15%) |
|
May 11, 2026
29d ago
|
Press Release
| $64.68 $65.32 | ▲ +0.99% | ▲ +1.07% | $67.37 (+4.16%) |
|
May 8, 2026
4w ago
|
S-3ASR
| $67.39 $69.66 | ▲ +3.37% | ▲ +1.90% | $67.37 (−0.03%) |
|
May 7, 2026
4w ago
|
Press Release
| $67.39 $69.66 | ▲ +3.37% | ▲ +1.90% | $67.37 (−0.03%) |
|
May 6, 2026
4w ago
|
Press Release
| $68.09 $65.95 | ▼ −3.14% | ▼ −4.27% | $67.37 (−1.06%) |
|
May 5, 2026
5w ago
|
Press Release
| $68.78 $65.95 | ▼ −4.11% | ▼ −6.10% | $67.37 (−2.05%) |
Showing 10 of 15
US Market Status
Market Closed — Opens in 2h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access